Table 4 Clinical data for dogs with idiopathic and structural epilepsy included in the multivariable analysis
Variables | Number of dogs | ||
|---|---|---|---|
All epilepsy cases (n = 94) | IdE (n = 64) | StE (n = 30) | |
Gender | |||
Male [Neuter] | 52 (55 %) [24 (26 %)] | 37 (58 %) [18 (28 %)] | 15 (50 %) [6 (20 %)] |
Female [Neuter] | 42 (45 %) [17 (18 %)] | 27 (42 %) [11 (17 %)] | 15 (50 %) [6 (20 %)] |
Body weight (kg) | |||
Median | 6.6 | 7.0 | 6.1 |
Range | 1.3–35.0 | 1.3–31.0 | 2.0–35.0 |
Age at initial seizure onset (years) | |||
Median | 3.1 | 2.7 | 6.0 |
Range | 0.4–10.0 | 0.6–6.8 | 0.4–10.0 |
Neurological | |||
Normal or unremarkable | 71 (76 %) | 62 (97 %) | 9 (30 %) |
Deficits | 23 (24 %) | 2 (3 %) | 21 (70 %) |
Seizure frequency at last follow-up (sz/month) | |||
Median | 3.3 | 2.5 | 4.0 |
Range | 0.1–20.0 | 0.1–20.0 | 0.1–10.0 |
Seizure type | |||
FES | 20 (21 %) | 15 (23 %) | 5 (17 %) |
GES | 51 (55 %) | 30 (47 %) | 21 (70 %) |
FEvG | 23 (24 %) | 19 (30 %) | 4 (13 %) |
Specific seizure pattern | |||
CS | 43 (46 %) | 26 (41 %) | 17 (57 %) |
SE | 16 (17 %) | 13 (20 %) | 3 (10 %) |
Using AEDs at last follow-up | |||
None | 46 (49 %) | 37 (58 %) | 11 (37 %) |
Monotherapy | 35 (37 %) | 18 (28 %) | 10 (33 %) |
Polytherapy | 13 (14 %) | 9 (14 %) | 9 (30 %) |
Using other treatment | |||
No | 69 (73 %) | 60 (94 %) | 9 (30 %) |
Yes | 25 (27 %) | 4 (6 %) | 21 (70 %) |